pSF-CAG-Ub-Puro (OG600) CAG Promoter Puromycin Resistant Vector

Product Code: OG600R1
Product Code: OG600C1
Product Code: OG600G1

Product Description

CAG promoter puromycin resistant vector. Puromycin expression is controlled by the Ubiquitin promoter positioned away from the MCS

Plasmid Information

Product Name: pSF-CAG-Ub-Puro

Product Code: OG600

Size (bp): 7265 bp

Bacterial Antibiotic Selection: KanR

Origin and Compatibility: pUC high copy derived from pBR322

Bacterial Copy Number: 500-700 per cell

Promoter: CAG synthetic mammalian promoter and Ubiquitin promoter / Chicken Beta Actin (CBA) promoter / Human Ubiquitin Promoter

Plasmid Purpose:

In this vector the CAG promoter is upstream of the MCS (where your gene of interest can be easily inserted) and puromycin resistance gene is under control of the ubiquitin promoter. CAG is a synthetic composite of the CMV immediate early enhancer followed by the CBA promoter and the rabbit beta globin intron and provide high level and durable expression in mammalian cells.

Promoter Expression Level:

This plasmid contains the mammalian CAG promoter which is a synthetic composite of the CMV immediate early enhancer followed by the CBA promoter and the rabbit beta globin intron. The Chicken beta actin contains a CpG island that can help to keep the promoter active for longer in stable culture when compared to the CMV promoter. The ubiquitin promoter that is driving expression of the puromycin gene demonstrates a high level of expression in most cell types. It demonstrates similiar levels of expression to the commonly used EF1-Alpha promoter.

Please login or sign up to view the sequence & maps
Transcription Termination:

This plasmid contains three alternative transcription terminators for mammalian bacterial and bacteriophage (T7) expression. This means that only the promoter needs to be changed to alter the expression system you are using. We sell multiple promoters that can be used in each of these systems. The presence of each terminator does not reduce expression in the alternative systems.

Cloning in a Gene:

This plasmid has been designed to be compatible with a range of cloning techniques. The multiple cloning site contains a range of standard commonly used restriction sites for cloning. Using these sites genes can be inserted using standard cloning methods with DNA ligase. Other methods such as ligase independent cloning (LIC) Gibson Assembly InFusionHD or Seamless GeneArt can also be used and because all of our plasmids are based on the same backbone the same method can be used for cloning into all of our catalogue vectors.

Multiple cloning site notes:

There are a few important sites within the MCS. These include the NcoI site the XbaI site and the BsgI and BseRI sites. The NcoI site contains a start codon that is immediately downstream of both a Kozak and Shine-Dalgarno ribosomal binding site. These allow for optimal positioning of genes when the start codon is placed in this location. If this is not required and you wish to use a downstream site for gene cloning you can remove the NcoI site by cleaving the plasmid with KpnI.

The XbaI site contains a stop codon. This stop codon is positioned in a specific position in relation to the BsgI and BseRI sites that are immediately downstream. When either BseRI or BsgI cleave the plasmid they produce a TA overhang from the stop codon in the XbaI site that is compatible with all of our peptide tag plasmids cut with the same sites. BseRI and BsgI sites are non-palindromic and cleave a defined number of bases away from their binding site.

Whenever we clone a gene into our multiple cloning site we always position the start and stop codon in the same positions in the MCS. If the start and ends of the genes are not compatible with NcoI and XbaI we extend the sequence to the nearest external sites but keep the start and stop codons locations consistent.

Intellectual Property Status

This product is part of our SnapFast™ plasmid range, for more information on the intellectual property status of this plasmid please click here. For more information on the terms of our licences please click here.